Raymond James Financial Inc. Invests $609,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Raymond James Financial Inc. acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 90,107 shares of the company’s stock, valued at approximately $609,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in RXRX. Decker Retirement […]